Mark Capper

Founded and lead KGI, a strategy and innovation practice focused on helping organizations navigate complex, high-stakes challenges—particularly in healthcare, life sciences, and technology. My work centers on connecting insight, foresight, and execution—helping teams move beyond understanding problems to aligning around decisions and driving meaningful outcomes. I’ve partnered with global organizations including Costco, Google, Amazon, Mercedes-Benz, BMW Group, Tropicana, and Agilent, leading initiatives across: * Customer and patient insight (VoC, UX, Jobs to Be Done) * Market and opportunity assessment * Experience and product strategy * Strategic foresight and scenario-based planning * Cross-functional alignment and decision support A core focus of my work is enabling teams to anticipate and navigate challenges earlier—before they become visible problems—by improving how insight is generated, shared, and acted on across the organization. In addition to client work, I’ve developed frameworks and approaches that integrate AI and advanced analytics into strategic decision-making, helping organizations operate with greater clarity, speed, and resilience.

Advised on the development of AI-focused strategy offerings and supported leadership teams in evaluating where AI could drive meaningful business value. * Contributed to frameworks for assessing AI opportunities, risks, and organizational readiness * Supported executive discussions on where to apply AI—and where not to—based on business impact * Focused on translating AI capabilities into practical, decision-oriented use cases Currently paused to focus on direct client work and growth strategy engagements.

Contract Project Manager – CMC & Program Management Wave Life Sciences | 2022 – 2023 - Led integrated CMC planning and execution to establish CDMO model for RNA therapeutics - Coordinated cross-functional teams across CMC, Quality, Manufacturing, Regulatory, and Supply Chain - Developed and managed integrated project timelines (Smartsheet), including dependencies and critical path - Maintained risk registers and drove mitigation planning across program workstreams - Partnered with stakeholders on budget planning, tracking, and resource alignment - Supported GMP production readiness and alignment with clinical timelines - Co-led workshops with Quality and Regulatory to prepare the organization for GMP-level governance prior to clinical trials - Translated complex technical inputs into clear program plans and decision-ready insights for leadership

Partnered with the Chief Innovation Officer at Bristol Myers Squibb to support the development of digital health strategy and operating models for Cell & Gene Therapy initiatives. * Helped define governance structures and decision frameworks to guide digital health innovation in a highly regulated environment * Advised on prioritization, investment focus, and operating models for patient-facing digital solutions * Translated complex clinical, regulatory, and technology inputs into clear strategic direction and actionable recommendations * Aligned cross-functional teams across Capgemini, frog, and Fahrenheit 212 to ensure consistency across strategy, innovation, and execution.

- Led integrated CMC project management across Drug Substance, Drug Product, Analytical, Quality, Regulatory, and Supply Chain - Drove execution of CMC plans aligned with clinical, regulatory, and commercialization milestones - Facilitated cross-functional Product Team meetings, including agenda development, decision documentation, and action tracking - Developed and maintained integrated project timelines (Smartsheet) - Managed risks, issues, and escalation pathways; maintained risk registers - Partnered with Product Teams and Finance on budget planning, tracking, and forecasting - Coordinated preparation of governance materials for cross-functional program reviews - Provided end-to-end lifecycle support from development through clinical and

Partnered with senior client leadership to shape innovation, brand, and portfolio strategy, translating customer and market insight into clear, actionable business decisions. * Led multidisciplinary teams integrating qualitative and quantitative research, cultural insight, and strategic analysis to identify growth opportunities and guide product and brand decisions * Advised executives on product development, brand positioning, and portfolio strategy, supporting high-impact investment and go-to-market decisions * Helped organizations align on priorities, evaluate tradeoffs, and move forward with clear strategic direction across complex and uncertain environments * Delivered work across global and regional markets, supporting both near-term growth initiatives and longer-term strategic planning Selected clients include: Kimberly-Clark Healthcare, Johnson & Johnson DePuy, BMW, Royal Dutch Shell, Coca-Cola Global, Harley-Davidson, Yamaha Motor Corporation, Diageo, and Babolat.